13.04.2015 • NewsadhesivesaminesChemical

Oxea Extends Partnership with IMCD to Strengthen Distribution of Amines in Europe

Following two years of successful co-operation, the global chemical company Oxea has extended its distribution partnership with the Dutch chemical distributor IMCD for its Amines in Europe.

Starting in April, the new contract will allow IMCD to distribute Oxea's TCD Diamine in Europe. TCD Diamine is used as a high performance epoxy resin hardener in surface coating systems and specialty adhesives.

"Over the past two years the co-operation with IMCD has continued to exceed expectations on both sides. Thanks to IMCD we have significantly widened the scope of our European customer base. In line with our strategy to grow our derivatives business further, we therefore decided to extend the pan-European distribution partnership with IMCD to include TCD Diamine," said Michael Harbich, European Marketing Manager at Oxea.

"It is a very exciting opportunity for IMCD to build on its existing successful partnership with Oxea for the distribution of Amines," said Dr. Stephen Rosenthal, Market Manager at IMCD. "We are confident that the new contract for TCD Diamine will further strengthen our product portfolio and allows customers from the coatings and adhesives industries in Europe to look to IMCD for all of their formulation needs."

In a recent study by the Fraunhofer Institute for Manufacturing Technology and Advanced Materials IFAM in Bremen, Germany, TCD Diamine has yielded very favorable results for epoxy based adhesive technologies. The product and further details of the study will be presented at Oxea's exhibition booth in hall 1, stand 516, at the European Coatings Show in Nuremberg, Germany, from April 21 to 23, 2015.

 

Company

Logo:

Oxea

Rheinpromenade 4a
40789 Monheim am Rhein
Germany

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.